Condition
Non-alcoholic Fatty Liver Disease NAFLD clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Non-alcoholic Fatty Liver Disease NAFLD clinical trials that are recruiting, at sites in 8 countries (most in France (2), Hong Kong (1), United States (1)). By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 8Countries
Newest Non-alcoholic Fatty Liver Disease NAFLD clinical trials
All recruiting trials (9)
-
ECC4703 with Sulfasalazine and Pitavastatin in adults with NAFLD and dyslipidemia
This early study tests whether adding ECC4703 to sulfasalazine and pitavastatin is safe and how the body handles the combination in adults with fatty liver disease and high cholesterol.
-
Taiwan green propolis for MASLD and lipid/metabolic issues
This study tests whether Taiwan green propolis capsules can improve blood lipids and body fat in adults with MASLD compared to a placebo over 12 weeks.
-
Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD
This program automatically screens high‑risk adults aged 50–75 in primary care to see if they have advanced liver fibrosis and possible MASLD, using routine blood tests and reflex lab tests without extra work for clinicians.
-
Single-cell and spatial mapping of liver degeneration and regeneration
This project will try to use single-cell and spatial omics on preoperative blood and discarded liver tissue from people having liver surgery or biopsy to map how cells change during fatty liver, HBV infection, fibrosis, and cirrhosis.
-
Testing QX1206 in patients with Type 2 Diabetes and fatty liver disease
This study is testing a new treatment called QX1206 to see if it can help adults with Type 2 diabetes and fatty liver disease manage their blood sugar and improve their health.
-
MRI biomarkers to detect NASH in adults with fatty liver
This project will try MRI measurements to see if they can detect NASH in adults with fatty liver who are already scheduled for a liver biopsy.
-
Investigating Milk Thistle for Pediatric Fatty Liver Disease
This study is testing whether Milk Thistle can help children and young adults with Non-Alcoholic Fatty Liver Disease feel better while also making lifestyle changes.
-
Screening for advanced liver fibrosis in patients with fatty liver disease or alcohol-related liver issues
This study is testing two blood tests to see which one better helps doctors find advanced liver damage in people with fatty liver disease or alcohol-related liver problems.
-
Long-term observation of Chinese patients with fatty liver disease
This study looks at how Non-Alcoholic Fatty Liver Disease and its more serious form affect Chinese patients over 10 years to learn more about their causes, progression, and treatment options.
Related topics
Quick answers
How many Non-alcoholic Fatty Liver Disease NAFLD clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in France (2 trials), Hong Kong (1 trial), United States (1 trial), China (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.